logo
  

Innoviz Technologies Posts Narrower Loss In Q4 - Quick Facts

Innoviz Technologies Ltd. (INVZ) posted a fourth quarter net loss of $30.45 million compared to a loss of $34.32 million, last year. Loss per share was $0.18 compared to a loss of $0.25. On average, five analysts polled by Thomson Reuters expected the company to report a loss per share of $0.18, for the quarter. Analysts' estimates typically exclude special items.

Fourth quarter revenues increased to $14.92 million from $1.58 million, previous year. Analysts on average had estimated $11.2 million in revenue.

The company expects first quarter revenues to be in the range of $5 million-$6 million.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission announced that it has opened formal proceedings against Meta Platforms to assess whether the owner of Facebook and Instagram may have breached the Digital Services Act or DSA in areas linked to the protection of minors. On the Nasdaq Stock Exchange, Meta shares were losing around 1.1 percent. Retail giant Walmart reported Thursday a profit for the first quarter that soared from last year, reflecting higher gross margins and strong growth across all its operating segments. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. While reporting financial results for the first quarter on Thursday, retail giant Walmart, Inc. (WMT) initiated its adjusted earnings and net sales growth guidance for the second quarter, well above analysts' estimates. It also maintained full-year 2025 outlook. For the second quarter, the company...

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
RELATED NEWS
Follow RTT